Cannabis firm Tilray’s revenue up, but wider loss reported

Be at the forefront of cannabis and psychedelics science and innovation. Register by March 14 & Save $100 on tickets to The Emerald Conference by MJBiz Science, April 1-3 in San Diego.


Canadian marijuana company Tilray on Tuesday reported revenue of 60.9 million Canadian dollars ($45.9 million) for the second quarter, up almost four times from the same period in 2018.

Net loss for the period, which ended June 30, was $35.05 million compared with a $12.83 million loss in the second quarter 2018.

Tilray, based in British Columbia, trades as TLRY on the Nasdaq.

The company’s share price was up over 8% in trading after the results were released.

More details can be found here.